Last reviewed · How we verify
bosutinib capsules in water
bosutinib capsules in water is a Small molecule drug developed by Pfizer. It is currently in Phase 1 development.
At a glance
| Generic name | bosutinib capsules in water |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Palatability (Taste) of Oral Formulations of Bosutinib (PHASE1)
- Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- bosutinib capsules in water CI brief — competitive landscape report
- bosutinib capsules in water updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about bosutinib capsules in water
What is bosutinib capsules in water?
bosutinib capsules in water is a Small molecule drug developed by Pfizer.
Who makes bosutinib capsules in water?
bosutinib capsules in water is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What development phase is bosutinib capsules in water in?
bosutinib capsules in water is in Phase 1.
Related
- Manufacturer: Pfizer — full pipeline